Related Experiment Video
Updated: Aug 7, 2026

Generation of Patient-Derived Podocytes from Skin Biopsies
Published on: May 26, 2023
Cyclin I protects podocytes from apoptosis
Siân V Griffin1, J Paul Olivier, Jeffrey W Pippin
1Department of Medicine, Division of Nephrology, University of Washington School of Medicine, Seattle, 98195, USA.
Abstract:
The limited regenerative capacity of the glomerular podocyte following injury underlies the development of glomerulosclerosis and progressive renal failure in a diverse range of kidney diseases. We discovered that, in the kidney, cyclin I is uniquely expressed in the glomerular podocyte, and have constructed cyclin I knock-out mice to explore the biological function of cyclin I in these cells. Cyclin I knock-out (-/-) podocytes showed an increased susceptibility to apoptosis both in vitro and in vivo. Following induction of experimental glomerulonephritis, podocyte apoptosis was increased 4-fold in the cyclin I -/- mice, which was associated with dramatically decreased renal function. Our previous data showed that the Cdk inhibitor p21(Cip1/Waf1) protects podocytes from certain apoptotic stimuli. In cultured cyclin I -/- podocytes, the level of p21(Cip1/Waf1) was lower at base line, had a shorter half-life, and declined more rapidly in response to apoptotic stimuli than in wild-type cells. Enforced expression of p21(Cip1/Waf1) reversed the susceptibility of cyclin I -/- podocytes to apoptosis. Cyclin I protects podocytes from apoptosis, and we provide preliminary data to suggest that this is mediated by stabilization of p21(Cip1/Waf1).
Insights
Cyclin I deficiency in kidney podocytes increases their apoptosis and worsens kidney disease. Stabilizing p21(Cip1/Waf1) may protect these vital kidney cells.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Glomerular podocyte injury limits kidney regeneration, leading to glomerulosclerosis and renal failure.
- Cyclin I is uniquely expressed in glomerular podocytes, suggesting a specific role in kidney function.
Purpose of the Study:
- To investigate the biological function of cyclin I in glomerular podocytes.
- To determine the role of cyclin I in podocyte apoptosis and its contribution to kidney disease.
Main Methods:
- Generation and analysis of cyclin I knock-out ( -/- ) mice.
- In vitro and in vivo assessment of podocyte apoptosis.
- Experimental glomerulonephritis induction in wild-type and cyclin I -/- mice.
- Analysis of p21(Cip1/Waf1) levels and half-life in cultured podocytes.
Main Results:
- Cyclin I -/- podocytes exhibited increased apoptosis in vitro and in vivo.
- Podocyte apoptosis was significantly elevated in cyclin I -/- mice following glomerulonephritis induction, correlating with reduced renal function.
- p21(Cip1/Waf1) levels were lower and less stable in cyclin I -/- podocytes.
- Enforced expression of p21(Cip1/Waf1) rescued cyclin I -/- podocytes from apoptosis.
Conclusions:
- Cyclin I protects glomerular podocytes from apoptosis.
- This protection is potentially mediated by cyclin I's role in stabilizing p21(Cip1/Waf1).
- Targeting cyclin I or p21(Cip1/Waf1) may offer therapeutic strategies for kidney diseases involving podocyte injury.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
The Extrinsic Apoptotic Pathway
